α-Glucosidase-IN-11

Modify Date: 2024-04-06 17:54:52

α-Glucosidase-IN-11 Structure
α-Glucosidase-IN-11 structure
Common Name α-Glucosidase-IN-11
CAS Number 2411744-76-6 Molecular Weight 420.41
Density N/A Boiling Point N/A
Molecular Formula C23H20N2O6 Melting Point N/A
MSDS N/A Flash Point N/A

 Use of α-Glucosidase-IN-11


α-Glucosidase-IN-11 is a highly permeable competitive α-glucosidase inhibitor with the IC50 value of 0.56 μM. α-Glucosidase-IN-11 binds to Trp residues in α-glucosidase and regulates protein folding. α-Glucosidase-IN-11 can be used to regulate blood glucose levels[1].

 Names

Name α-Glucosidase-IN-11

 α-Glucosidase-IN-11 Biological Activity

Description α-Glucosidase-IN-11 is a highly permeable competitive α-glucosidase inhibitor with the IC50 value of 0.56 μM. α-Glucosidase-IN-11 binds to Trp residues in α-glucosidase and regulates protein folding. α-Glucosidase-IN-11 can be used to regulate blood glucose levels[1].
Related Catalog
In Vitro α-Glucosidase-IN-11 (compound 3k) inhibits α-glucosidase, α-fucosidase and α-mannosidase with the IC50 value of 0.56 μM, 30.4 μM and 41.2 μM, respectively[1]. α-Glucosidase-IN-11 (compound 3k) ( 0.1-100 μM, 24 hours) can induce β-cell proliferation at lower concentration[1]. Cell Proliferation Assay[1] Cell Line: BRIN-BD11 cells (rat beta cell line) Concentration: 0.1-100 μM Incubation Time: 24 hours Result: Showed cell proliferation at low concentration of 1 μM and minor cytotoxic effect at higher concentration greater than 10 μM.
In Vivo α-Glucosidase-IN-11 (compound 3k) (gastric gavage, 60 mg/kg, everyday, 4 weeks) can improve blood glucose levels during fasting[1]. Animal Model: Male Sprague Dawley rats (250e320g)[1] Dosage: 60 mg/kg Administration: Gastric gavage; everyday; 4 weeks Result: Caused a significant drop in fasting blood glucose during the first and second weeks but did not cause a decrease in non-fasting blood glucose for up to four weeks.
References

[1]. Tania Luthra, et al. Discovery of novel pyrido-pyrrolidine hybrid compounds as alpha-glucosidase inhibitors and alternative agent for control of type 1 diabetes. Eur J Med Chem. 2020 Feb 15;188:112034.

 Chemical & Physical Properties

Molecular Formula C23H20N2O6
Molecular Weight 420.41